Skip to main content
Top
Published in: Medical Microbiology and Immunology 2-3/2004

01-05-2004 | Original Investigation

Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency

Authors: Ralph Feuer, Ignacio Mena, Robb R. Pagarigan, Daniel E. Hassett, J. Lindsay Whitton

Published in: Medical Microbiology and Immunology | Issue 2-3/2004

Login to get access

Abstract

Coxsackieviruses (CV) are characterized by their ability to cause cytopathic effects in tissue culture and by their capacity to initiate acute disease by inducing apoptosis within targeted organs in vivo. These viruses are considered highly cytolytic, but can establish persistence/latency in susceptible cells, indicating that a regulatory mechanism may exist to shut off viral protein synthesis and replication under certain situations. The persistence of coxsackieviral RNA is of particular medical interest due to its association with chronic human diseases such as dilated cardiomyopathy and chronic inflammatory myopathy. Here, we discuss the potential mechanisms regulating coxsackievirus replication, and the ability of viral RNA to remain in an apparent latent state within quiescent cells.
Literature
1.
go back to reference Archard LC, Khan MA, Soteriou BA, Zhang H, Why HJ, Robinson NM, Richardson PJ (1998) Characterization of Coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products. Hum Pathol 29:578–584 Archard LC, Khan MA, Soteriou BA, Zhang H, Why HJ, Robinson NM, Richardson PJ (1998) Characterization of Coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products. Hum Pathol 29:578–584
2.
go back to reference Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P (2001) Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344:1750–1757PubMed Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P (2001) Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344:1750–1757PubMed
3.
go back to reference Billeter MA, Cattaneo R, Spielhofer P, Kaelin K, Huber M, Schmid A, Baczko K, Meulin V ter (1994) Generation and properties of measles virus mutations typically associated with subacute sclerosing panencephalitis. Ann N Y Acad Sci 724:367–377 Billeter MA, Cattaneo R, Spielhofer P, Kaelin K, Huber M, Schmid A, Baczko K, Meulin V ter (1994) Generation and properties of measles virus mutations typically associated with subacute sclerosing panencephalitis. Ann N Y Acad Sci 724:367–377
4.
go back to reference Brodsky VY, Sarkisov DS, Arefyeva AM, Panova NW (1993) DNA and protein relations in cardiomyocytes. Growth reserve in cardiac muscle. Eur J Histochem 37:199–206 Brodsky VY, Sarkisov DS, Arefyeva AM, Panova NW (1993) DNA and protein relations in cardiomyocytes. Growth reserve in cardiac muscle. Eur J Histochem 37:199–206
5.
go back to reference Couderc T, Girard S, Pelletier I, Gosselin AS, Destombes J, Thiesson D, Colbere-Garapin F, Blondel B (2001) Inhibition of poliovirus RNA synthesis as a molecular mechanism contributing to viral persistence in the mouse central nervous system. Dev Biol (Basel) 105:225–230 Couderc T, Girard S, Pelletier I, Gosselin AS, Destombes J, Thiesson D, Colbere-Garapin F, Blondel B (2001) Inhibition of poliovirus RNA synthesis as a molecular mechanism contributing to viral persistence in the mouse central nervous system. Dev Biol (Basel) 105:225–230
6.
go back to reference Dalakas MC (1986) New neuromuscular symptoms in patients with old poliomyelitis: a three- year follow-up study. Eur Neurol 25:381–387 Dalakas MC (1986) New neuromuscular symptoms in patients with old poliomyelitis: a three- year follow-up study. Eur Neurol 25:381–387
7.
go back to reference Dalakas MC (1987) New neuromuscular symptoms after old polio ("the post-polio syndrome"): clinical studies and pathogenetic mechanisms. Birth Defects Orig Artic Ser 23:241–264 Dalakas MC (1987) New neuromuscular symptoms after old polio ("the post-polio syndrome"): clinical studies and pathogenetic mechanisms. Birth Defects Orig Artic Ser 23:241–264
8.
go back to reference Dalakas MC, Elder G, Hallett M, Ravits J, Baker M, Papadopoulos N, Albrecht P, Sever J (1986) A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms. N Engl J Med 314:959–963 Dalakas MC, Elder G, Hallett M, Ravits J, Baker M, Papadopoulos N, Albrecht P, Sever J (1986) A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms. N Engl J Med 314:959–963
9.
go back to reference De la Fuente G, Palacios O, Villagra E, Villanueva ME (1995) Isolation of Coxsackieviruses B5 in a fatal case of meningoencephalitis. Rev Med Chil 123:1510–1513PubMed De la Fuente G, Palacios O, Villagra E, Villanueva ME (1995) Isolation of Coxsackieviruses B5 in a fatal case of meningoencephalitis. Rev Med Chil 123:1510–1513PubMed
10.
go back to reference Destombes J, Couderc T, Thiesson D, Girard S, Wilt SG, Blondel B (1997) Persistent poliovirus infection in mouse motoneurons. J Virol 71:1621–1628 Destombes J, Couderc T, Thiesson D, Girard S, Wilt SG, Blondel B (1997) Persistent poliovirus infection in mouse motoneurons. J Virol 71:1621–1628
11.
go back to reference Endl E, Gerdes J (2000) The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res 257:231–237PubMed Endl E, Gerdes J (2000) The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res 257:231–237PubMed
12.
go back to reference Estes ML, Rorke LB (1986) Liquefactive necrosis in Coxsackie B encephalitis. Arch Pathol Lab Med 110:1090–1092 Estes ML, Rorke LB (1986) Liquefactive necrosis in Coxsackie B encephalitis. Arch Pathol Lab Med 110:1090–1092
13.
go back to reference Feuer R, Mena I, Pagarigan RR, Slifka MK, Whitton JL (2002) Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J Virol 76:4430–4440 Feuer R, Mena I, Pagarigan RR, Slifka MK, Whitton JL (2002) Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J Virol 76:4430–4440
14.
go back to reference Fujioka S, Kitaura Y, Ukimura A, Deguchi H, Kawamura K, Isomura T, Suma H, Shimizu A (2000) Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 36:1920–1926 Fujioka S, Kitaura Y, Ukimura A, Deguchi H, Kawamura K, Isomura T, Suma H, Shimizu A (2000) Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 36:1920–1926
15.
go back to reference Gage FH (2000) Mammalian neural stem cells. Science 287:1433–1438PubMed Gage FH (2000) Mammalian neural stem cells. Science 287:1433–1438PubMed
16.
go back to reference Gascon GG (1996) Subacute sclerosing panencephalitis. Semin Pediatr Neurol 3:260–269PubMed Gascon GG (1996) Subacute sclerosing panencephalitis. Semin Pediatr Neurol 3:260–269PubMed
17.
go back to reference Gauntt CJ, Jones DC, Huntington HW, Arizpe HM, Gudvangen RJ, DeShambo RM (1984) Murine forebrain anomalies induced by coxsackievirus B3 variants. J Med Virol 14:341–355 Gauntt CJ, Jones DC, Huntington HW, Arizpe HM, Gudvangen RJ, DeShambo RM (1984) Murine forebrain anomalies induced by coxsackievirus B3 variants. J Med Virol 14:341–355
18.
go back to reference Girard S, Gosselin AS, Pelletier I, Colbere-Garapin F, Couderc T, Blondel B (2002) Restriction of poliovirus RNA replication in persistently infected nerve cells. J Gen Virol 83:1087–1093PubMed Girard S, Gosselin AS, Pelletier I, Colbere-Garapin F, Couderc T, Blondel B (2002) Restriction of poliovirus RNA replication in persistently infected nerve cells. J Gen Virol 83:1087–1093PubMed
19.
go back to reference Hassett DE, Zhang J, Slifka MK, Whitton JL (2000) Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization. J Virol 74:2620–2627 Hassett DE, Zhang J, Slifka MK, Whitton JL (2000) Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization. J Virol 74:2620–2627
20.
go back to reference Henke A, Huber SA, Stelzner A, Whitton JL (1995) The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 69:6720–6728 Henke A, Huber SA, Stelzner A, Whitton JL (1995) The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 69:6720–6728
21.
go back to reference Huber M, Watson KA, Selinka HC, Carthy CM, Klingel K, McManus BM, Kandolf R (1999) Cleavage of RasGAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication. J Virol 73:3587–3594PubMed Huber M, Watson KA, Selinka HC, Carthy CM, Klingel K, McManus BM, Kandolf R (1999) Cleavage of RasGAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication. J Virol 73:3587–3594PubMed
22.
go back to reference Huber SA, Haisch C, Lodge PA (1990) Functional diversity in vascular endothelial cells: role in coxsackievirus tropism. J Virol 64:4516–4522 Huber SA, Haisch C, Lodge PA (1990) Functional diversity in vascular endothelial cells: role in coxsackievirus tropism. J Virol 64:4516–4522
23.
go back to reference Julien J, Leparc-Goffart I, Lina B, Fuchs F, Foray S, Janatova I, Aymard M, Kopecka H (1999) Postpolio syndrome: poliovirus persistence is involved in the pathogenesis. J Neurol 246:472–476 Julien J, Leparc-Goffart I, Lina B, Fuchs F, Foray S, Janatova I, Aymard M, Kopecka H (1999) Postpolio syndrome: poliovirus persistence is involved in the pathogenesis. J Neurol 246:472–476
24.
go back to reference Kaplan MH, Klein SW, McPhee J, Harper RG (1983) Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis 5:1019–1032 Kaplan MH, Klein SW, McPhee J, Harper RG (1983) Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis 5:1019–1032
25.
go back to reference Kim KS, Hufnagel G, Chapman NM, Tracy S (2001) The group B coxsackieviruses and myocarditis. Rev Med Virol 11:355–368 Kim KS, Hufnagel G, Chapman NM, Tracy S (2001) The group B coxsackieviruses and myocarditis. Rev Med Virol 11:355–368
26.
go back to reference Klingel K, Rieger P, Mall G, Selinka HC, Huber M, Kandolf R (1998) Visualization of enteroviral replication in myocardial tissue by ultrastructural in situ hybridization: identification of target cells and cytopathic effects. Lab Invest 78:1227–1237PubMed Klingel K, Rieger P, Mall G, Selinka HC, Huber M, Kandolf R (1998) Visualization of enteroviral replication in myocardial tissue by ultrastructural in situ hybridization: identification of target cells and cytopathic effects. Lab Invest 78:1227–1237PubMed
27.
go back to reference Li Y, Peng T, Yang Y, Niu C, Archard LC, Zhang H (2000) High prevalence of enteroviral genomic sequences in myocardium from cases of endemic cardiomyopathy (Keshan disease) in China. Heart 83:696–701 Li Y, Peng T, Yang Y, Niu C, Archard LC, Zhang H (2000) High prevalence of enteroviral genomic sequences in myocardium from cases of endemic cardiomyopathy (Keshan disease) in China. Heart 83:696–701
28.
go back to reference Liu P, Aitken K, Kong YY, Opavsky MA, Martino T, Dawood F, Wen WH, Kozieradzki I, Bachmaier K, Straus D, Mak TW, Penninger JM (2000) The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease. Nat Med 6:429–434 Liu P, Aitken K, Kong YY, Opavsky MA, Martino T, Dawood F, Wen WH, Kozieradzki I, Bachmaier K, Straus D, Mak TW, Penninger JM (2000) The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease. Nat Med 6:429–434
29.
go back to reference Luo H, Yanagawa B, Zhang J, Luo Z, Zhang M, Esfandiarei M, Carthy C, Wilson JE, Yang D, McManus BM (2002) Coxsackievirus B3 replication Is reduced by inhibition of the extracellular signal-regulated Kinase (ERK) signaling pathway. J Virol 76:3365–3373CrossRefPubMed Luo H, Yanagawa B, Zhang J, Luo Z, Zhang M, Esfandiarei M, Carthy C, Wilson JE, Yang D, McManus BM (2002) Coxsackievirus B3 replication Is reduced by inhibition of the extracellular signal-regulated Kinase (ERK) signaling pathway. J Virol 76:3365–3373CrossRefPubMed
30.
go back to reference Mena I, Perry CM, Harkins S, Rodriguez F, Gebhard JR, Whitton JL (1999) The role of B lymphocytes in coxsackievirus B3 infection. Am J Pathol 155:1205–1215 Mena I, Perry CM, Harkins S, Rodriguez F, Gebhard JR, Whitton JL (1999) The role of B lymphocytes in coxsackievirus B3 infection. Am J Pathol 155:1205–1215
31.
go back to reference Mena I, Fischer C, Gebhard JR, Perry CM, Harkins S, Whitton JL (2000) Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology. Virology 271:276–288 Mena I, Fischer C, Gebhard JR, Perry CM, Harkins S, Whitton JL (2000) Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology. Virology 271:276–288
32.
go back to reference Modlin JF, Rotbart HA (1997) Group B coxsackie disease in children. Curr Top Microbiol Immunol 223:53–80 Modlin JF, Rotbart HA (1997) Group B coxsackie disease in children. Curr Top Microbiol Immunol 223:53–80
34.
go back to reference Norris CM, Danis PG, Gardner TD (1999) Aseptic meningitis in the newborn and young infant. Am Fam Physician 59:2761–2770 Norris CM, Danis PG, Gardner TD (1999) Aseptic meningitis in the newborn and young infant. Am Fam Physician 59:2761–2770
35.
go back to reference Opavsky MA, Martino T, Rabinovitch M, Penninger J, Richardson C, Petric M, Trinidad C, Butcher L, Chan J, Liu PP (2002) Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J Clin Invest 109:1561–1569CrossRefPubMed Opavsky MA, Martino T, Rabinovitch M, Penninger J, Richardson C, Petric M, Trinidad C, Butcher L, Chan J, Liu PP (2002) Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J Clin Invest 109:1561–1569CrossRefPubMed
36.
go back to reference Pilipenko EV, Pestova TV, Kolupaeva VG, Khitrina EV, Poperechnaya AN, Agol VI, Hellen CU (2000) A cell cycle-dependent protein serves as a template-specific translation initiation factor. Genes Dev 14:2028–2045 Pilipenko EV, Pestova TV, Kolupaeva VG, Khitrina EV, Poperechnaya AN, Agol VI, Hellen CU (2000) A cell cycle-dependent protein serves as a template-specific translation initiation factor. Genes Dev 14:2028–2045
37.
go back to reference Pyronnet S, Pradayrol L, Sonenberg N (2000) A cell cycle-dependent internal ribosome entry site. Mol Cell 5:607–616 Pyronnet S, Pradayrol L, Sonenberg N (2000) A cell cycle-dependent internal ribosome entry site. Mol Cell 5:607–616
38.
go back to reference Ramirez JC, Fairen A, Almendral JM (1996) Parvovirus minute virus of mice strain i multiplication and pathogenesis in the newborn mouse brain are restricted to proliferative areas and to migratory cerebellar young neurons. J Virol 70:8109–8116 Ramirez JC, Fairen A, Almendral JM (1996) Parvovirus minute virus of mice strain i multiplication and pathogenesis in the newborn mouse brain are restricted to proliferative areas and to migratory cerebellar young neurons. J Virol 70:8109–8116
39.
go back to reference Reetoo KN, Osman SA, Illavia SJ, Cameron-Wilson CL, Banatvala JE, Muir P (2000) Quantitative analysis of viral RNA kinetics in coxsackievirus B3-induced murine myocarditis: biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease. J Gen Virol 81:2755–2762PubMed Reetoo KN, Osman SA, Illavia SJ, Cameron-Wilson CL, Banatvala JE, Muir P (2000) Quantitative analysis of viral RNA kinetics in coxsackievirus B3-induced murine myocarditis: biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease. J Gen Virol 81:2755–2762PubMed
40.
go back to reference Tam PE, Messner RP (1999) Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J Virol 73:10113–10121PubMed Tam PE, Messner RP (1999) Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J Virol 73:10113–10121PubMed
41.
go back to reference Tam PE, Schmidt AM, Ytterberg SR, Messner RP (1991) Viral persistence during the developmental phase of Coxsackievirus B1-induced murine polymyositis. J Virol 65:6654–6660 Tam PE, Schmidt AM, Ytterberg SR, Messner RP (1991) Viral persistence during the developmental phase of Coxsackievirus B1-induced murine polymyositis. J Virol 65:6654–6660
42.
go back to reference Tam PE, Schmidt AM, Ytterberg SR, Messner RP (1994) Duration of virus persistence and its relationship to inflammation in the chronic phase of coxsackievirus B1-induced murine polymyositis. J Lab Clin Med 123:346–356 Tam PE, Schmidt AM, Ytterberg SR, Messner RP (1994) Duration of virus persistence and its relationship to inflammation in the chronic phase of coxsackievirus B1-induced murine polymyositis. J Lab Clin Med 123:346–356
43.
go back to reference Tsunoda I, Fujinami RS (1996) Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J Neuropathol Exp Neurol 55:673–686 Tsunoda I, Fujinami RS (1996) Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J Neuropathol Exp Neurol 55:673–686
44.
go back to reference Wessely R, Henke A, Zell R, Kandolf R, Knowlton KU (1998) Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. Circulation 98:450–457PubMed Wessely R, Henke A, Zell R, Kandolf R, Knowlton KU (1998) Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. Circulation 98:450–457PubMed
45.
go back to reference Wessely R, Klingel K, Santana LF, Dalton N, Hongo M, Jonathan LW, Kandolf R, Knowlton KU (1998) Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest 102:1444–1453PubMed Wessely R, Klingel K, Santana LF, Dalton N, Hongo M, Jonathan LW, Kandolf R, Knowlton KU (1998) Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest 102:1444–1453PubMed
46.
go back to reference Wynford-Thomas D, Williams ED (1986) Use of bromodeoxyuridine for cell kinetic studies in intact animals. Cell Tissue Kinet 19:179–182 Wynford-Thomas D, Williams ED (1986) Use of bromodeoxyuridine for cell kinetic studies in intact animals. Cell Tissue Kinet 19:179–182
47.
go back to reference Zhang J, Silvestri N, Whitton JL, Hassett DE (2002) Neonates mount robust and protective adult-like CD8+ T cell responses to DNA vaccines. J Virol 76:11911–11919 Zhang J, Silvestri N, Whitton JL, Hassett DE (2002) Neonates mount robust and protective adult-like CD8+ T cell responses to DNA vaccines. J Virol 76:11911–11919
Metadata
Title
Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency
Authors
Ralph Feuer
Ignacio Mena
Robb R. Pagarigan
Daniel E. Hassett
J. Lindsay Whitton
Publication date
01-05-2004
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 2-3/2004
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-003-0192-z

Other articles of this Issue 2-3/2004

Medical Microbiology and Immunology 2-3/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.